Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children

Intratumoral injections of recombinant heat shock protein (Hsp)70 were explored for feasibility in patients with brain tumors. Patients aged 4.5–14 years with untreated newly diagnosed tumors (n=12) were enrolled. After tumor resection, five injections of recombinant Hsp70 (total 2.5 mg) were admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Shevtsov, Maxim A, Kim, Alexander V, Samochernych, Konstantin A, Romanova, Irina V, Margulis, Boris A, Guzhova, Irina V, Yakovenko, Igor V, Ischenko, Alexander M, Khachatryan, William A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069152/
https://www.ncbi.nlm.nih.gov/pubmed/24971017
http://dx.doi.org/10.2147/OTT.S62764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069152/
https://www.ncbi.nlm.nih.gov/pubmed/24971017
http://dx.doi.org/10.2147/OTT.S62764

Ejemplares similares